Article info

NSGS mice humanized with cord blood mononuclear cells show sustained and functional myeloid–lymphoid representation with limited graft-versus-host disease

Authors

  • Carla Panisello Josep Carreras Leukaemia Research Institute (IJC), Barcelona, SpainRed Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (ISCIII), Madrid, SpainGermans Trias i Pujol Research Institute (IGTP), Badalona, Spain PubMed articlesGoogle scholar articles
  • Rosario Aschero Paediatric Cancer Treatment, Sant Joan de Deu Research Institute, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Alba Martinez-Moreno Josep Carreras Leukaemia Research Institute (IJC), Barcelona, SpainRed Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (ISCIII), Madrid, Spain PubMed articlesGoogle scholar articles
  • Heleia Roca Ho Josep Carreras Leukaemia Research Institute (IJC), Barcelona, SpainRed Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (ISCIII), Madrid, Spain PubMed articlesGoogle scholar articles
  • Aida Falgas Josep Carreras Leukaemia Research Institute (IJC), Barcelona, SpainRed Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (ISCIII), Madrid, Spain PubMed articlesGoogle scholar articles
  • Europa Azucena González-Navarro Department of Immunology and Immunotherapy, Hospital Clínic Barcelona, Barcelona, SpainAugust Pi i Sunyer Institute of Biomedical Research (IDIBAPS), Barcelona, Spain PubMed articlesGoogle scholar articles
  • Julieta Carabelli IrsiCaixa AIDS Research Institute, Badalona, Spain PubMed articlesGoogle scholar articles
  • Edwards Pradenas IrsiCaixa AIDS Research Institute, Badalona, Spain PubMed articlesGoogle scholar articles
  • María Lázaro-Díez IrsiCaixa AIDS Research Institute, Badalona, Spain PubMed articlesGoogle scholar articles
  • Julia G Prado Germans Trias i Pujol Research Institute (IGTP), Badalona, SpainIrsiCaixa AIDS Research Institute, Badalona, SpainCentro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain PubMed articlesGoogle scholar articles
  • Julià Blanco Germans Trias i Pujol Research Institute (IGTP), Badalona, SpainIrsiCaixa AIDS Research Institute, Badalona, SpainCentro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII), Madrid, SpainDepartment of Microbiology, Universitat Autònoma de Barcelona, Bellaterra, Spain PubMed articlesGoogle scholar articles
  • Jorge Carrillo Germans Trias i Pujol Research Institute (IGTP), Badalona, SpainIrsiCaixa AIDS Research Institute, Badalona, SpainCentro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain PubMed articlesGoogle scholar articles
  • Manel Juan Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (ISCIII), Madrid, SpainDepartment of Immunology and Immunotherapy, Hospital Clínic Barcelona, Barcelona, SpainAugust Pi i Sunyer Institute of Biomedical Research (IDIBAPS), Barcelona, Spain PubMed articlesGoogle scholar articles
  • Ángel M Carcaboso Paediatric Cancer Treatment, Sant Joan de Deu Research Institute, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Clara Bueno Josep Carreras Leukaemia Research Institute (IJC), Barcelona, SpainRed Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (ISCIII), Madrid, SpainCentro Investigación Biomédica en Red en Oncología (CIBERONC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain PubMed articlesGoogle scholar articles
  • Pablo Menendez Josep Carreras Leukaemia Research Institute (IJC), Barcelona, SpainRed Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (ISCIII), Madrid, SpainCentro Investigación Biomédica en Red en Oncología (CIBERONC), Instituto de Salud Carlos III (ISCIII), Madrid, SpainInstitució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, SpainDepartament of Biomedicine, School of Medicine, Universitat de Barcelona, Barcelona, Spain PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Pablo Menendez; pmenendez{at}carrerasresearch.org; Dr Clara Bueno; cbueno{at}carrerasresearch.org
View Full Text

Citation

Panisello C, Aschero R, Martinez-Moreno A, et al
NSGS mice humanized with cord blood mononuclear cells show sustained and functional myeloid–lymphoid representation with limited graft-versus-host disease

Publication history

  • Accepted September 16, 2024
  • First published October 7, 2024.
Online issue publication 
October 07, 2024
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.